NCT02764723View on ClinicalTrials.gov

Isobaric Spinal Ropivacaine Versus Hyperbaric Spinal Bupivacaine in Total Knee Arthroplasty in Geriatric Patients

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Total Knee Arthroplasty in Geriatric PatientsSpinal Anesthesia
Interventions
DRUG

Hyperbaric bupivacaine

12.5 mg of hyperbaric bupivacaine 0.5% for spinal anesthesia in geriatric patients undergoing total knee arthroplasty

DRUG

Isobaric ropivacaine

15 mg of isobaric ropivacaine 0.5% for spinal anesthesia in geriatric patients undergoing total knee arthroplasty

All Listed Sponsors
lead

Mohamed Sayed Mohamed Abbas

OTHER

NCT02764723 - Isobaric Spinal Ropivacaine Versus Hyperbaric Spinal Bupivacaine in Total Knee Arthroplasty in Geriatric Patients | Biotech Hunter | Biotech Hunter